Rulonilimab Chemical Properties

form 

Liquid

color 

Colorless to light yellow

Rulonilimab Usage And Synthesis

Uses

Rulonilimab is a human IgG1 monoclonal antibody against PD-1 that targets, binds and inhibits PD-1 and its downstream signalling pathways with potential immune checkpoint inhibition and anti-tumour activity[1].

References

[1] Phase Ⅱ/III Studies to Investigate the Efficacy and Safety of Rulonilimab in Combination With Lenvatinib Compared to Placebo in Combination With Lenvatinib as First-Line Therapy in Subjects With Hepatocellular Carcinoma (HCC).

Rulonilimab(2417124-95-7)Related Product Information

• Bectumomab
• EV2-7
• Romilkimab
• Navivumab
• Anumigilimab
• Quetmolimab
• Bezlotoxumab
• Talquetamab
• Lirentelimab
• Lacnotuzumab